IRB
Advarra Integrates IRB with Veeva Vault eTMF, Delivers Unparalleled Efficiency for a Top 10 Biopharma
Teamwork and leadership from an industry-leading biopharmaceutical company and Advarra accomplish integration through Veeva Vault eTMF, saving over 8000 hours in the first 6 months.
Informed Consent: 6 Approaches to Increase Participant Comprehension
Explore six approaches for improving informed consent and supporting participants’ understanding of the studies they are asked to join.
Managing Conflicts of Interest in Clinical Research
Managing conflicts of interest in clinical research is a critical mission for many reasons. Here we discuss the need for conflict of interest policies in clinical research, examine the specific ...
Botanical Medicines in Research
Botanicals have been used for millennia to combat illness—but why are there so few clinical trials testing the merits of this modality? This whitepaper describes rationale for why IRBs should ...
Special Considerations for Pediatric Trials
In this white paper, get to know the key considerations for researchers conducting pediatric clinical trials.
10 Tips for Writing Compliant Participant Materials
Recruitment materials are a potential participant’s first introduction to the study, and post-consent materials can influence an individual’s decision about continued participation. It is important to adhere to the principles ...
Research in Pediatric Populations
It is vitally important to develop effective and safe treatments for children based on reliable data from clinical trials involving child participants. However, conducting research with children presents unique ethical ...
6 Tips for Submitting a Research Study for Expedited Review
Becoming familiar with the expedited requirements is a good way to ensure you can navigate the review process effectively.
Key Biosafety Considerations for Coronavirus Research
Advarra Director of Biosafety Daniel Eisenman reviews opportunities, risks, and risk mitigation strategies for coronavirus research. Read more:
Reefer Sanity: IRB Review That Won’t Vaporize Cannabis Protocols
Cannabis and cannabis-derived products are being used with increasing frequency in both recreational and therapeutic settings. With more widespread use of cannabis, how can data from well-designed clinical research trials ...
Revised Common Rule Compliance Now in Full Effect—and What That Means
The Revised Common Rule is here after multiple delays, exceptions, and many training sessions. As of January 20, 2020, this regulation is in full effect.
What Level of Review Does Your Study Need?
In this infographic, we share useful information for investigators to know which level of IRB review likely applies to their study.
Subscribe to our monthly email
Receive updates monthly about webinars for CEUs, white papers, podcasts, and more.
Advancing Clinical Research: Safer, Smarter, Faster™
Copyright © 2024 Advarra. All Rights Reserved.